Novo's head of diabetes marketing discusses how the company is reaching patients and what it learned from the Wegovy pill rollout.
Recap by typeshit. Full story at Fierce Pharma.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
A JAMA Network Surgery study found GLP-1 prescriptions up 24% since 2018, while a Tulane surgeon says Louisiana insurance favors surgery.
A JAMA Network Surgery study found GLP-1 prescriptions up 24% since 2018. A Tulane surgeon says in Louisiana, surgery is more often covered than the drugs.
Loading…